The NeuroPass device. [Image from CraniUS] CraniUS Therapeutics announced today that it raised $20 million in a Series B financing round to accelerate its development of NeuroPass. NeuroPass is a ...

First you’ll need to setup a Java project for Maven to build. To keep the focus on Maven, make the project as simple as possible for now. package hello; public ...

For the first time, Americans with depression will soon be able to use a prescription brain-stimulation device at home. The approval comes from the U.S. Food and Drug Administration and marks a major ...

U & U GYAN BRAINS TECH PRIVATE LIMITED is a Private Limited Company, governed by the Companies Act as a company limited by shares. Classified as a Non-government company, it is registered under the ...

The final, formatted version of the article will be published soon. A proposed interdisciplinary fetal neonatal neurology collaborative offers life-course brain health training across three ...

According to @ai_darpa, Neuralink is advancing its AI-powered brain-computer interface technology with its latest project, Blindsight, aiming to restore vision even for individuals born blind or ...

The human brain has four distinct turning points where its structure changes, according to a study published in the journal Nature Communications, demonstrating that brain development is not as linear ...

Neuroscientists have detected five broad phases of brain structure in the average human life, split up by four pivotal turning points between birth and death when our brains reconfigure. Childhood ...

“I was feeling more attracted by optics, especially lasers,” he explained, “so I specialised in optical measurement at the end of my master.” During his Ph.D. at the Weizmann Institute of Science in ...

Artificial intelligence systems that are designed with a biologically inspired architecture can simulate human brain activity before ever being trained on any data, according to new research from ...

A U.S. neurotechnology startup called Paradromics is gaining momentum in the fast-growing field of brain-computer interfaces. The FDA has approved its first human trial built to test whether its fully ...